» Authors » Daniela Sambataro

Daniela Sambataro

Explore the profile of Daniela Sambataro including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 184
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Valerio M, Scandurra G, Greco M, Gebbia V, Piazza D, Sambataro D
In Vivo . 2025 Feb; 39(2):1000-1008. PMID: 40010972
Background/aim: A high percentage of cancer patients use complementary therapies (CM) during their disease journey. Several barriers for CM prescription still exist among oncologists. This study explored oncologists' attitudes toward...
2.
Sambataro D, Gebbia V, Bonasera A, Quattrocchi A, Caputo G, Vinci E, et al.
Cancers (Basel) . 2025 Feb; 17(3). PMID: 39941769
Background: Brain metastases (BMs) from endometrial cancer (EC) are rare and challenging to treat, with limited standardized guidelines. This systematic review aims to evaluate the incidence, therapeutic strategies, and outcomes...
3.
Colombo A, Concetta P, Gebbia V, Sambataro D, Scandurra G, Valerio M
In Vivo . 2024 Dec; 39(1):25-36. PMID: 39740863
Patients affected by metastatic carcinoma of the colon/rectum (mCRC) harboring mutations in the BRAF gene (MBRAF) respond poorly to conventional therapy and have a prognosis worse than that of patients...
4.
Cipolla C, Gebbia V, DAgati E, Greco M, Mesi C, Scandurra G, et al.
Curr Oncol . 2024 Dec; 31(12):7566-7574. PMID: 39727680
Male breast cancer (MBC) is a rare disease, accounting for less than 1% of all breast cancer cases. Sentinel lymph node biopsy (SLNB) has emerged as a less invasive alternative...
5.
Scandurra G, Sambataro D, Gebbia V, Piazza D, Valerio M
J Cancer Educ . 2024 Oct; PMID: 39425870
Herpes zoster (HZ) virus reactivation is a significant medical problem among immunocompromised patients, especially considering its potential complications. Although the recombinant HZ vaccine has demonstrated > 90% efficacy against HZ...
6.
Lavalle S, Masiello E, Valerio M, Aliprandi A, Scandurra G, Gebbia V, et al.
Exp Ther Med . 2024 Aug; 28(4):381. PMID: 39113908
Immune checkpoint inhibitor (ICI) therapy has revolutionized cancer treatment by enhancing the immune response against tumor cells. However, their influence on immune pathways can lead to immune-related adverse events such...
7.
Scandurra G, Lombardo V, Scibilia G, Sambataro D, Gebbia V, Scollo P, et al.
Cancers (Basel) . 2024 Jul; 16(13). PMID: 39001528
Brain metastases (BM) pose a significant challenge in the management of HER2+ breast cancer since almost 50% of patients with HER2+ breast cancer develop brain tumors. The complex process of...
8.
Piazza D, Martorana F, Curaba A, Sambataro D, Valerio M, Firenze A, et al.
Curr Oncol . 2024 May; 31(5):2796-2804. PMID: 38785493
Introduction: In recent years, generative Artificial Intelligence models, such as ChatGPT, have increasingly been utilized in healthcare. Despite acknowledging the high potential of AI models in terms of quick access...
9.
Colombo N, Gadducci A, Landoni F, Lorusso D, Sabbatini R, Artioli G, et al.
Gynecol Oncol . 2023 Jun; 175:182-189. PMID: 37355448
Introduction: Standard treatment of newly diagnosed, advanced ovarian carcinoma (OC) consists of cytoreductive surgery followed by platinum-based chemotherapy with or without bevacizumab. Maintenance therapy with PARP inhibitors and olaparib-bevacizumab has...
10.
Sambataro D, Politi M, Messina A, Scarpello L, Messina S, Guggino R, et al.
Anticancer Res . 2023 May; 43(6):2821-2829. PMID: 37247899
Background/aim: Chronic inflammation and cytokine storm can cause uncontrolled events in cancer. Pro-inflammatory molecules released by malignant cells send signals to the brain, liver, and neuroendocrine cells, interfering with appetite...